Hormonal Contraceptive Trends and Forecast
The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.A more than 150-page report is developed to help in your business decisions.
Hormonal Contraceptive by Segment
The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:
- Pill
- Intrauterine Device
- Injectable
- Vaginal Ring
- Implant
- Patch
Hormonal Contraceptive Market by Hormone [Shipment Analysis by Value from 2018 to 2030]:
- Combination Hormonal Contraceptive
- Progestin Only
Hormonal Contraceptive Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Hormonal Contraceptive Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include:- AbbVie
- Afaxys
- Teva Pharmaceuticals Industries
- Bayer
- Organon
- Pfizer
- Agile Therapeutics
- Janssen Pharmaceutical
- Lupin Pharmaceutical
- Pregna International
Hormonal Contraceptive Market Insights
The publisher forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.Within this market, combination hormonal contraceptive will remain larger segment.
APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.
Features of the Global Hormonal Contraceptive Market
- Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).
- Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the hormonal contraceptive market size?Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.
Q2. What is the growth forecast for hormonal contraceptive market?
Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?
Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.
Q4. What are the major segments for hormonal contraceptive market?
Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.
Q5. Who are the key hormonal contraceptive market companies?
Answer: Some of the key hormonal contraceptive companies are as follows:
- AbbVie
- Afaxys
- Teva Pharmaceuticals Industries
- Bayer
- Organon
- Pfizer
- Agile Therapeutics
- Janssen Pharmaceutical
- Lupin Pharmaceutical
- Pregna International
Answer: The publisher forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.
Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Hormonal Contraceptive Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- AbbVie
- Afaxys
- Teva Pharmaceuticals Industries
- Bayer
- Organon
- Pfizer
- Agile Therapeutics
- Janssen Pharmaceutical
- Lupin Pharmaceutical
- Pregna International
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
